Vontobel Holding’s Adicet Bio ACET Stock Holding History

Vontobel Holding’s Portfolio ACET Stock Details ACET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$91.2K	Sell	12,775 -1,001	-7%	-$8.73K	﹤0.01%	1425
2026 Q2	$119K	Sell	13,776 -471	-3%	-$3.71K	﹤0.01%	1396
2026 Q1	$97K	Buy	+14,247	New	+$107K	﹤0.01%	1149
2025 Q4	–	Sell	-5,000	Closed	-$65.2K	–	1433
2025 Q3	$65.2K	Hold	5,000	–	–	﹤0.01%	1314
2025 Q2	$48.8K	Buy	5,000 +1,250	+33%	+$13.2K	﹤0.01%	1235
2025 Q1	$46.6K	Buy	3,750 +625	+20%	+$8.94K	﹤0.01%	1064
2024 Q4	$48.1K	Buy	3,125 +625	+25%	+$11.8K	﹤0.01%	1075
2024 Q3	$57.6K	Hold	2,500	–	–	﹤0.01%	1056
2024 Q2	$48.4K	Buy	2,500 +812	+48%	+$21.8K	﹤0.01%	1044
2024 Q1	$63.4K	Buy	+1,688	New	+$69.8K	﹤0.01%	1044

Other funds holding ACET

Carlyle Group Washington, District of Columbia $8.36B AUM 14.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Regeneron Pharmaceuticals Tarrytown, New York $180M AUM 18.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

Vontobel Holding's ACET Position: Q3 2026 in Review

Vontobel Holding reduced its Adicet Bio (ACET) stake by 7.3% in Q3 2026, selling an estimated $8.73K and leaving 12,775 shares worth $91.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1425.

Vontobel Holding first reported a position in ACET in Q1 2024 and has held it in 10 quarters since. The position peaked at $119K in Q2 2026. 17 funds tracked by Wall St. Rank hold ACET as of Q3 2026.

Vontobel Holding held 12,775 shares of Adicet Bio worth $91.2K as of Q3 2026.
Vontobel Holding sold 1,001 Adicet Bio shares in Q3 2026, an estimated $8.73K.
Adicet Bio made up ﹤0.01% of Vontobel Holding's portfolio in Q3 2026, its #1425 holding.
Vontobel Holding first reported a position in Adicet Bio in Q1 2024 and has held it in 10 quarters since.
Vontobel Holding's Adicet Bio position peaked at $119K in Q2 2026.
17 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2026.

Based on Vontobel Holding's 13F filing for Q3 2026, filed 16 Oct 2026.